Thiabendazole indications and usage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Thiabendazole}} {{CMG}} <ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintez..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Indications and Usage== | |||
MINTEZOL is indicated for the treatment of: | |||
* [[Strongyloidiasis]] (threadworm) | |||
<ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | publisher = | date = | accessdate = }}</ref> | * [[Cutaneous larva migrans]] (creeping eruption) | ||
* [[Visceral larva migrans]] | |||
* [[Trichinosis]]: Relief of symptoms and [[fever]] and a reduction of [[eosinophilia]] have followed the use of MINTEZOL during the invasion stage of the disease.<ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 22:49, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications and Usage
MINTEZOL is indicated for the treatment of:
- Strongyloidiasis (threadworm)
- Cutaneous larva migrans (creeping eruption)
- Trichinosis: Relief of symptoms and fever and a reduction of eosinophilia have followed the use of MINTEZOL during the invasion stage of the disease.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.